|
|
|
Our business model combines internal discovery research programs with a comprehensive range of from
genes to leads discovery services including gene expression, assay development, high-throughput screening (HTS) and compound profiling.
We offer two options for companies to work with us. We can provide our complete
range of drug discovery services and technologies on a fee-for-service basis
or through customized partnership arrangements involving risk sharing, milestone
payments and/or royalties.
If you are interested in joining our growing list of collaborations, please contact
us for partnering opportunities of our discovery services programs. |
|
|
|
|
|
|
